REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 33 filers reported holding REXAHN PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,040,000 | -47.7% | 7,326,681 | -22.6% | 0.06% | -18.9% |
| Q3 2016 | $1,988,000 | -12.8% | 9,464,849 | +4.3% | 0.07% | -37.8% |
| Q2 2016 | $2,279,000 | -47.7% | 9,071,168 | -31.3% | 0.12% | -45.4% |
| Q1 2016 | $4,361,000 | +330.5% | 13,212,254 | +487.0% | 0.22% | +230.3% |
| Q3 2013 | $1,013,000 | – | 2,250,840 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|